Figure 2
From: Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD
Transition dyspnoea index (TDI) score at week 12. BDP/FF, beclomethasone dipropionate/formoterol fumarate; FP/S, fluticasone propionate/salmeterol. There were no differences (p > 0.05) between BDP/FF and FP/S. The threshold for clinical relevance only applies to the TDI total domain score.